There is a lot of fundamental data that I rely on to help paint an overall picture about underlying strength of any stock I might consider using for a value-based investment. While some fundamental investors prefer to work with easy-to-reference, quick-glance data like earnings per share, I prefer to expand my view of a company’s […]
Read MoreFor most of the past year, any examination of the Pharmaceutical industry begins and ends with COVID-19 vaccines. Literally, of course, this isn’t true; diseases of all kinds don’t take a holiday during a pandemic, and so development of existing projects for any company in this industry hasn’t stopped, either. Nonetheless, the massive, immediate impact […]
Read MoreSince the beginning of the year, broad market momentum has mostly stalled. Investors seem to be confronting the reality that the pandemic’s economic effects appear set to linger well into the rest of this year, even as vaccinations across the country begin to increase and new vaccine candidates appear ready to apply for emergency use […]
Read MorePlus, the NYSE reversed course on their decision to not delist three Chinese telecoms, bitcoin rose to another new all-time high, and UnitedHealth is buying Change Healthcare.
Read MoreWith thousands of publicly available stocks to work with, the question most investors face when looking for ways to keep their money working for them isn’t really about which stocks they might be able to use. I’ve spent more than two decades watching the markets and studying different investing and trading styles and methods. What […]
Read MoreThe Consumer Discretionary sector includes stocks that cover a wide variety of the Retail industry. Because there are so many retail companies that offer different products to consumers, it’s hard to pinpoint any kind of specific niche. In the sporting goods niche, there were significant challenges even before COVID-19 became a global pandemic. Declining revenues […]
Read MoreEver since coronavirus found its way to American shores, a large amount of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. From the market’s bearish low in […]
Read MoreI hope everybody had a wonderful Thanksgiving holiday! I’ve written a lot in this space about my belief in defensive sectors and industries for more than a year now. The market is showing a lot of bullish momentum right now, but I think the initial relief that I attribute mostly to decreasing political uncertainty is […]
Read MoreOne of the most straightforward and useful ways for average investors like you and me to maintain an active investing approach without drowning in the massive volumes of news reports, analyst opinions and buzz around the thousands of publicly traded stocks is to work with our own watchlists. These are lists of stocks that you […]
Read MorePost-election, a lot of the focus for the markets has, not surprisingly shifted back to COVID and the pandemic that just won’t stop. Concern is increasing that the colder months of the year will make things even worse, and that a health care system that is already being strained as infections and hospitalizations are pushing […]
Read MoreOne trader says this stock looks primed to break out to new highs. Here’s why you may want to add it to your portfolio.
Read More